Armistice Capital’s Nexalin Technology Inc Warrant NXLIW Stock Holding History

Armistice Capital’s Portfolio NXLIW Stock Details NXLIW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-325,000	Closed	-$15.4K	–	371
2025 Q2	$15.4K	Hold	325,000	–	–	﹤0.01%	195
2025 Q1	$57.4K	Hold	325,000	–	–	﹤0.01%	210
2024 Q4	$114K	Hold	325,000	–	–	﹤0.01%	201
2024 Q3	$33.3K	Hold	325,000	–	–	﹤0.01%	245
2024 Q2	$111K	Hold	325,000	–	–	﹤0.01%	221
2024 Q1	$13.6K	Hold	325,000	–	–	﹤0.01%	325
2023 Q4	$2.86K	Hold	325,000	–	–	﹤0.01%	282
2023 Q3	$8.13K	Hold	325,000	–	–	﹤0.01%	246
2023 Q2	$35.8K	Sell	325,000 -1	-0%	–	﹤0.01%	208
2023 Q1	$30.9K	Buy	325,001 +1	+0%	–	﹤0.01%	216
2022 Q4	$65K	Hold	325,000	–	–	﹤0.01%	173
2022 Q3	$58K	Buy	+325,000	New	+$65K	﹤0.01%	189

Armistice Capital's NXLIW Position: Q3 2025 in Review

Armistice Capital sold out of Nexalin Technology Inc Warrant (NXLIW) in Q3 2025, closing a stake of 325,000 shares — an estimated $15.4K sold.

Armistice Capital first reported a position in NXLIW in Q3 2022 and held it in 12 quarters. The position peaked at $114K in Q4 2024. 0 funds tracked by Wall St. Rank hold NXLIW as of Q3 2025.

Armistice Capital reported no remaining Nexalin Technology Inc Warrant position as of Q3 2025 after selling out during the quarter.
Armistice Capital sold 325,000 Nexalin Technology Inc Warrant shares in Q3 2025, an estimated $15.4K.
Armistice Capital first reported a position in Nexalin Technology Inc Warrant in Q3 2022 and held it in 12 quarters.
Armistice Capital's Nexalin Technology Inc Warrant position peaked at $114K in Q4 2024.
0 funds tracked by Wall St. Rank held Nexalin Technology Inc Warrant as of Q3 2025.

Based on Armistice Capital's 13F filing for Q3 2025, filed 17 Nov 2025.